Clinical Trial Update: A 6 Week Study to Determine the Effectiveness of R228060 in Adult Subjects With Major Depressive Disorder [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluated the effectiveness of R228060 in adults with Major Depressive Disorder; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder

Drugs mentioned

• R228060

Snippet

Sponsor: Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | Conditions: Major Depressive Disorder | Phase 2 | Status: COMPLETED